Maintain pressure on reforms to protect NHSNew nasal spray to treat pain in cancer patients
An intranasal fentanyl spray (Instanyl) has been launched for the treatment of breakthrough pain experienced by patients with cancer.
The spray can be used by patients who are already taking maintenance opioid therapy for chronic cancer pain.
Maintenance therapy is defined as at least:
- 60 mg of oral morphine daily,
- 25 micrograms of transdermal fentanyl per hour,
- 30 mg oxycodone daily,
- 8 mg of oral hydromorphone daily
- or an equilivent dose of another opioid for a week or longer.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.